NeoGenomics, Inc.
(NASDAQ : NEO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Medical Or Nursing Services
symbolcompany%chnglast%shortavg$volume
DVADaVita HealthCare Partners Inc.
0.29%70.162.3%$103.64m
ACHCAcadia Healthcare Company, Inc.
-1.75%35.3127.3%$66.07m
AMEDAmedisys, Inc.
0.29%108.1011.7%$39.19m
MDMEDNAX, Inc.
-0.29%44.8510.1%$37.48m
CHEChemed Corporation
1.11%310.0310.0%$32.81m
LHCGLHC Group, Inc.
-0.12%90.322.9%$30.61m
ENSGEnsign Group, Inc.
2.24%38.635.9%$9.72m
ADUSAddus HomeCare Corporation
1.24%63.881.2%$9.64m
USPHU.S. Physical Therapy, Inc.
1.64%109.974.8%$9.31m
NEONeoGenomics, Inc.
3.34%13.946.9%$7.05m
RDNTRadNet, Inc.
3.07%16.130.5%$5.34m
FMSFresenius Medical Care AG & Co. KGaA Sponsored ADR
1.41%49.580.1%$5.23m
COChina Cord Blood Corporation
-2.60%6.750.3%$0.51m
AIQAlliance HealthCare Services, Inc.
1.63%14.690.5%$0.42m
VNRXVolitionrx Limited
-0.33%2.790.6%$0.36m

Company Profile

NeoGenomics, Inc. provides cancer diagnostics and pharma services. It operates through a network of cancer focused testing laboratories to provide genetic and molecular testing services. It offers various testing services, including Cytogenetics, Fluorescence In-Situ Hybridization, Flow Cytometry, Immunohistochemistry, Molecular testing and Pathology consultation. The company operates through one segment: Laboratory Testing Segment. The Laboratory Testing segment delivers testing services to hospitals, pathologists, oncologists, other clinicians and researchers. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.